Advertisement

Topics

Orchard’s ‘bubble baby’ therapy awarded PIM status

07:07 EDT 23 Aug 2017 | PharmaTimes

UK regulators have awarded Orchard Therapeutics’ experimental ‘bubble baby’ disease therapy OTL-101 Promising Innovative Medicine status, pushing the drug closer to being accepted onto the Early Access to Medicines Scheme.

Original Article: Orchard’s ‘bubble baby’ therapy awarded PIM status

NEXT ARTICLE

More From BioPortfolio on "Orchard’s ‘bubble baby’ therapy awarded PIM status"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...